MCCLUNG DAVID (Chief Financial Officer) purchased 11.2% of their position (4.82K shares) of BIOCARDIA, INC. on the open market
Open‑market purchase worth $10.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/2/2025ACC: 0001437749-25-022065
Officer· Chief Financial Officer
Since Sep 2018
+9.64K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
9.64K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.82K
Price / share
$2.08
Trade value
$10K
% of position
11.2%
6/30/2025
43.13K→47.95K
Total
Net shares
+4.82K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2025 | P · Purchase | +4.82K | $2.08 | $10K | 11.2% | 43.13K | 47.95K |
| Total | +4.82K | $10K | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common Stock
4.82K shares
Shares
+4.82K
Strike price
1.95
Held after
26.27K
Exercisable
—
6/30/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock4.82K shares | 6/30/2025 | P · Purchase | +4.82K | 1.95 | — | 26.27K |